Inclusion Criteria:  Male or female subjects 18-89 years of age Suspected or diagnosed vascular disease Standard of care carotid, chest, or Willingness to undergo 1 research MRA with up to double dose gadoterate meglumine Able to complete the MR safety questionnaire Able to comprehend and provide informed consent in English  Exclusion Criteria:  • Allergy to gadolinium-containing contrast media  Chronic, severe kidney disease eGFR < 60mL/min/1.73m2 Acute kidney injury Kidney or liver transplant within 8 weeks Contraindication to MRI (implanted device, claustrophobia, dyspnea precluding the ability to follow breath-hold instructions) Pregnant or breastfeeding women Adults unable to consent Individual who are not yet adults Prisoners